David Wright has been actively involved in brain imaging research for over 15 years. He completed his PhD in 2018 and is the director of preclinical imaging within the department of neuroscience at Monash University. In this role, Dr. Wright leads the scientific and academic direction of a ~$10-million facility purpose-built for small animal imaging. His research focuses on the development, application and translation of imaging biomarkers for neurodegenerative disease. Dr. Wright’s current research program is focussed on the glymphatic system – a brain-wide network of perivascular spaces that clears toxic dysfunctional protein from the brain. Despite receiving his PhD less than 5 years ago, Dr. Wright has published more 70 peer-reviewed articles. He has an average of 33.8 citations per publication, with 25% appearing in the top 10% of most cited worldwide (SciVal).
Using Sleep Modulation to Enhance the Brain’s Waste Clearance Mechanisms as an Approach to Limiting the Progression of Parkinson’s Disease